Condition

MCI

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 21 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials21
Recruiting7
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

21 shown
A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic EfficacyNCT07580703 · 2026-04-23
RECRUITING
Exploring the Utility of [18F]3F4AP for Demyelination ImagingNCT06999434 · 2025-05-05
RECRUITING
Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative DiseasesNCT07235111 · 2025-02-28
RECRUITING
Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's DiseaseNCT06850597 · 2024-10-28
RECRUITING
The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Subjective Cognitive Decline, SCD)NCT06335836 · 2024-03-01
RECRUITING
Neurocognitive Assessment Platform 4 AlzheimerNCT07272811 · 2021-12-15
RECRUITING
Cognitive Impairment in Ageing PeopleNCT04360200 · 2020-04-01
RECRUITING
Validation Study of a New Digital Diagnostic and Treatment Test Based on Interactive Video Games for Alzheimer's DiseaseNCT06963879 · 2025-05-01
ENROLLING_BY_INVITATION
Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers.NCT06223438 · 2024-01-12
COMPLETED
Validation and Reliability of the Turkish Version of the Montreal Cognitive Assessment-Basic (MoCA-B) in Individuals With Low Educational LevelNCT07630688 · 2024-01-01
COMPLETED
iPACES v3 MCI NIA Protocol Copied for iPACES v4 PD NINDSNCT05810454 · 2023-08-01
UNKNOWN
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)NCT05637801 · 2022-12-13
COMPLETED
The Interactive Physical and Cognitive Exercise System (v3) for Mild Cognitive Impairment (MCI)NCT05009524 · 2021-08-23
UNKNOWN
Validation Study of a New Digital Treatment TestNCT04897464 · 2021-06-01
UNKNOWN
BRain Energy Activation With Ketones to Prevent Alzheimer's DiseaseNCT04466735 · 2020-10-15
COMPLETED
Bilateral Brain Dynamics in Cognition and AgingNCT03224988 · 2018-03-20
COMPLETED
The Interactive Physical and Cognitive Exercise SystemNCT03069391 · 2017-03-04
UNKNOWN
Detecting Dementia EarlierNCT03900936 · 2017-01-19
UNKNOWN
Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's DiseaseNCT02380573 · 2015-07-01
COMPLETED
Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's DiseaseNCT02176629 · 2014-08-01
COMPLETED
Early Detection of Cognitive Dysfunction in DiabetesNCT01830998 · 2012-01-01
UNKNOWN

Common interventions

Trial status mix

COMPLETED7
RECRUITING7
UNKNOWN6
ENROLLING_BY_INVITATION1

Phase mix

NA8
PHASE12
PHASE22
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.